🇺🇸

US SEC Filing Intelligence

· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — July 17, 2026

Fuse Science, Inc. has entered a formal insolvency proceeding with the appointment of a receiver by the Clark County District Court, marking a definitive end to its operational viability. The company reported zero assets and zero cash as of December 31, 2026, and has relocated its headquarters and assets abroad, signaling a complete capital erosion. The receiver has been granted sweeping authority to investigate insider transactions, claw back improperly issued shares, and wind down the business, which introduces significant legal and reputational risk for former insiders. This filing represents a total loss for equity holders and underscores the severe consequences of sustained operational failure and potential governance lapses. The lack of any period-over-period improvements, forward guidance, or insider buying reinforces the terminal nature of this situation, making it a clear cautionary case for distressed-debt and event-driven investors.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — July 17, 2026

The 42 filings reveal a busy day for board and officer changes, with 28 separate appointments or departures across 19 companies. Most changes are routine, but several carry strategic significance: Energy Vault's appointment of a BlackRock veteran as CFO hints at a push toward commercial-scale capital raising, while Bunker Hill Mining's affirmative ESG rating and mine restart progress suggest an operational inflection point. Period-over-period data, though sparse in many filings, shows Karyopharm Therapeutics implementing a $3.7 million cash retention program, replacing a bonus plan to lock in key talent during a catalyst-rich period. Overall, the tone is neutral-to-positive, with only one clearly negative departure (Raphael Pharmaceutical's chairman and CFO resignations) and one mixed event (Cloudastructure's failed authorized share decrease). Insider trading activity is absent, but forward-looking statements in 12 filings point to upcoming catalyst events, including leadership transitions, compensation milestones, and option repricings. The aggregate data suggests a market environment where companies are proactively refreshing boards and retaining talent amid sector-specific tailwinds in energy, mining, and AI infrastructure.

42 high priority 42 total filings
· daily

USA Insider Trading Pulse — July 17, 2026

The July 17, 2026, insider trading pulse reveals a bifurcated market with significant capital deployment by large institutional holders in financials and real estate, contrasted by systematic insider selling in the technology sector. The most notable event is Sumitomo Mitsui Financial Group's massive $319M open-market purchase of Jefferies Financial Group, signaling strong conviction in the investment banking cycle. Concurrently, multiple Manulife entities collectively invested over $78M in John Hancock GA Mortgage Trust, indicating a bullish outlook on mortgage credit. On the bearish side, a cluster of C-suite executives at CIENA Corp executed pre-planned sales totaling over $3M, while a director at AEHR TEST SYSTEMS sold $1.64M post-gift, creating a negative technical signal. The day was dominated by routine equity awards (33 out of 50 filings), which are neutral but provide a baseline for tracking insider accumulation. A notable positive outlier is the CEO of Elevance Health, who deployed $753K of personal capital into the open market, a strong vote of confidence in the managed care sector. The data suggests a 'risk-on' rotation into financials and real estate, while tech insiders are taking profits.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — July 17, 2026

The July 17, 2026 US M&A digest reveals a bifurcated SPAC market: new issuance remains robust with two IPOs totaling $425M (Freedom Metals, Mercator Acquisition), while existing vehicles show mixed progress—one deal amendment (Inflection Point/GOWell), one termination with a pivot (Four Leaf/Data443), and one completed merger (Jet.AI/flyExclusive). Outside the SPAC space, two significant asset transactions closed: Braemar Hotels sold three properties for $432.7M (netting a $158.2M non-recurring gain), and Sadot Group acquired TradeIQ software IP for $6M. The most dilutive event is Jasper Therapeutics' acquisition of Kira Pharmaceuticals, where existing Jasper shareholders will own just 6.68% of the combined entity post-$132M PIPE. A notable period-over-period trend is the absence of revenue growth data in most filings, as SPACs and pre-revenue biotechs dominate. Insider activity is limited to a single director resignation (Activate Energy), providing no bullish conviction signals. Forward-looking data points to key catalysts: Jasper's pipeline milestones through 2028, Jet.AI's 90-day post-closing adjustment, and the Four Leaf/Data443 deal timeline.

12 high priority 12 total filings
· monthly

US Pre-Market SEC Filings Roundup — July 17, 2026

Overnight SEC filings reveal a market bifurcated between aggressive capital deployment and fundamental deterioration. The most dominant theme is a wave of transformative M&A and capital markets activity, including NextEra Energy's $2.25 billion deal to acquire Dominion Energy, IPG Photonics' €300 million acquisition of Lumibird Medical, and Jasper Therapeutics' dilutive $132 million PIPE-funded merger with Kira Pharmaceuticals. However, this optimism is counterbalanced by severe operational stress in several sectors. Frequency Electronics reported a dramatic swing from a $23.7M profit to a $0.9M loss, while AITX's cash position dwindled to just $95K against $44.9M in current liabilities. Insider activity is sending mixed signals: a massive $319M purchase by Sumitomo Mitsui in Jefferies Financial Group signals strong institutional conviction, while a $1.8M sale by Marvell's Data Center President raises questions about peak valuation. The financial sector shows a clear divergence, with Truist and Fifth Third posting strong YoY earnings growth driven by fee income and M&A integration, while Regions Financial reported flat revenue and elevated net charge-offs. The SPAC market remains active but challenged, with Papaya Growth's cash trust depleting and Sigyn Therapeutics deregistering entirely, highlighting the ongoing shakeout in blank-check companies.

29 high priority 21 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — July 16, 2026

This digest covers $409 million in federal construction and infrastructure contracts awarded to three contractors, all from civilian agencies (HHS and VA), with zero defense-related awards. The dominant theme is healthcare facility modernization, led by Whiting-Turner's $302 million NIH Building 10 renovation, which is roughly 55% complete and signals steady institutional construction demand. The highest-conviction signal is the VA's dual SDVOSB set-aside awards to AMCOR JV ONE LLC ($58 million) and The Trevino Group ($49 million), reflecting sustained policy support for veteran-owned businesses in healthcare IT infrastructure. Key risks include fixed-price execution risk on the two VA contracts, particularly The Trevino Group's $48.9 million project with no outlayed funds yet, and the potential for budget disruptions from a continuing resolution given the October-December vulnerability window for civilian agency contracts.

3 total filings
· daily

DHS Homeland Security Contracts — July 16, 2026

This digest covers two civilian Department of Homeland Security (DHS) contracts totaling $147.6 million, with zero defense exposure, underscoring a stable but non-cyclical procurement environment for homeland security and telecom infrastructure. The highest-conviction signal is a bullish $73 million AT&T Enterprises award under the DHS Enterprise Infrastructure Solutions (EIS) program, which reinforces AT&T’s competitive position in federal telecom and offers a potential $133 million upside if options are exercised. A neutral $74.6 million Smiths Detection sole-source award for TSA explosive detection systems shows strong execution (70% funded) but carries fixed-price margin risk. Key watch items include TSA’s future procurement strategy for detection systems and DHS budget allocations for IT/telecom, which will determine option exercise likelihood.

2 total filings
· daily

VA Healthcare & Services Contracts — July 16, 2026

Over a single-day period, the Department of Veterans Affairs awarded two firm-fixed-price construction contracts totaling $106.9 million, both exclusively to Service Disabled Veteran Owned Small Businesses (SDVOSBs). The aggregate is entirely civilian (0% defense), reflecting sustained VA investment in healthcare IT infrastructure and facility modernization. The highest-conviction signal is the $58.1 million EHRM infrastructure upgrade award to AMCOR JV ONE LLC for San Juan, PR, which carries medium pricing risk due to its 3.4-year fixed-price structure. A key risk is that both contracts are fixed-price, transferring cost overrun exposure to small contractors with limited balance sheets, particularly for The Trevino Group's $48.9 million Houston facility project, which has high pricing risk and no outlayed funds yet.

2 total filings
· daily

HHS & Healthcare Contracts Intelligence — July 16, 2026

This digest covers a single $57.3 million civilian contract from the Department of Health and Human Services (HHS) to Harvard College, a non-profit educational institution, for tuberculosis immunity research under NIH/NIAID. The award is cost-no-fee, generating zero profit for the recipient, and carries a neutral signal strength of 1/10 with no defense-related exposure. The dominant theme is steady, non-commercial NIH funding for infectious disease research, which is immaterial to public equity investors. Key risk: this contract displaces no for-profit competitors and offers no direct investment catalyst. The aggregate total obligation is $57,273,777, with zero defense contracts and zero bullish or bearish signals identified.

1 total filings
· daily

New Federal Contractors — July 16, 2026

This digest of 20 new federal contracts, totaling $1.39 billion, reveals a heavily civilian-dominated procurement environment, with only one defense-related award (Northrop Grumman's $80.6M NASA MAPS contract) among the mix. The dominant themes are infrastructure modernization at HHS/NIH ($302M Whiting-Turner) and aviation surveillance at DOT/FAA ($70.7M L3Harris SBS II sole-source), alongside steady IT services wins for Booz Allen Hamilton ($109M combined) and Accenture Federal Services ($47M at DOE). The highest-conviction signal is L3Harris's $913.4M total potential SBS II contract, which provides multi-year revenue visibility and underscores its entrenched position in FAA surveillance. Key risks include execution pressure on fixed-price construction contracts (Whiting-Turner, Trevino Group) and the vulnerability of civilian agency awards to continuing resolution uncertainty in Q4 2026.

20 total filings
· daily

Significant Contract Modifications ($10M+) — July 16, 2026

This digest of 20 significant contract modifications, totaling $1.39 billion, reveals a pronounced civilian agency focus, with only one defense-related award. The dominant theme is stable, recurring revenue from IT modernization and infrastructure projects at agencies like HHS, NASA, and the VA. The highest-conviction signal is L3Harris's $913.4 million sole-source SBS II contract with the FAA, providing a substantial, predictable revenue stream. A key risk is the high concentration of firm-fixed-price contracts (12 of 20), which transfer cost overrun risk to contractors, particularly for smaller firms like The Trevino Group and AMCOR JV ONE LLC.

20 total filings
· daily

Contract Deobligations Alert — July 16, 2026

This digest covers 20 government contracts totaling $1.39 billion, with only one defense-related award (5% of total value), underscoring a civilian-heavy procurement stream dominated by Health and Human Services ($518M), Homeland Security ($148M), and Transportation ($119M). The highest-conviction signal is L3Harris's sole-source SBS II contract with the FAA, valued at $913M potential over five years, indicating a durable incumbent position in aviation surveillance. A key risk is the concentration of fixed-price contracts (13 of 20) that transfer cost overrun risk to contractors, particularly for smaller firms like The Trevino Group and AMCOR JV ONE LLC on large construction projects. Investors should monitor option exercises on L3Harris's SBS II and AT&T's EIS contract as catalysts for revenue visibility.

20 total filings
· daily

Contract Option Exercises — July 16, 2026

This digest covers 20 contract option exercises totaling $1.39 billion, with only one defense-related award (5% of total value), underscoring a civilian-agency-dominated procurement environment. The dominant theme is federal infrastructure modernization—spanning NIH facility renovations, VA hospital upgrades, and FAA surveillance systems—with the highest-conviction signal being L3Harris’s $913.4 million sole-source SBS II contract, which provides multi-year revenue visibility. However, the heavy reliance on firm-fixed-price contracts (70% of total value) introduces execution risk, particularly for smaller set-aside recipients like AMCOR JV ONE LLC and The Trevino Group, Inc. Key watch items include the exercise of options on L3Harris’s SBS II and the potential impact of continuing resolution uncertainty on October–December 2026 awards.

20 total filings
· daily

Federal Professional Services Contracts — July 16, 2026

This digest covers $172.2 million in aggregate obligations from three civilian agency contracts, with zero defense exposure, underscoring a pure civilian-sector theme. The highest-conviction signal is L3Harris Technologies' sole-source, $913.4 million potential SBS II contract with the FAA, offering predictable long-term revenue but carrying fixed-price execution risk. A secondary bullish signal comes from NEXTGEN FEDERAL SYSTEMS' $53.4 million HUBZone set-aside with GSA FEDSIM, highlighting stable demand for small business engineering services. The key risk is concentration in the FAA and GSA, with no defense diversification, making the portfolio vulnerable to civilian budget pressures or a continuing resolution.

3 total filings
· daily

Federal IT & Cybersecurity Contracts — July 16, 2026

Over a single-day snapshot (July 16, 2026), this digest covers $266.5 million in total obligations across five civilian-agency IT contracts—0% defense-related. The dominant theme is civilian digital modernization, with Four Points Technology’s $62.2M (potential $401M ceiling) Census/AWS BPA call as the highest-materiality award. Booz Allen Hamilton leads in aggregate civilian IT revenue with two awards totaling $109.3M (CDC/GSA). The highest-conviction signal is Deloitte’s $48.2M HUD delivery order (options to $122.6M) rated bullish. Key risk: Accenture Federal Services (foreign-owned) awarded a DOE firm-fixed-price contract now approaching July 2026 expiry, creating re-compete uncertainty.

5 total filings
· daily

NASA & Space Contracts Intelligence — July 16, 2026

This digest covers a single, high-conviction NASA contract award to Advanced Space LLC valued at $51.4M (base), with a total potential value of $95.6M including options. The contract is a firm-fixed-price, small business set-aside for the CAPSTONE extended mission, signaling strong NASA confidence in the company's deep space R&D capabilities. The award is defense-related in the context of national space strategy, but is a civilian NASA procurement. The key bullish signal is the multi-year revenue visibility for a private small business, while the primary risk is medium pricing risk given the fixed-price nature of the contract.

1 total filings
· daily

All HHS Contracts — July 16, 2026

This digest covers $518.9 million in HHS contracts awarded between 2014 and 2022, with zero defense-related exposure. The dominant theme is NIH facility and research spending, led by a $302.1 million Whiting-Turner construction contract for Building 10 renovation, which accounts for 58% of total value and signals steady institutional infrastructure demand. The highest-conviction signal is a bullish $48.8 million award to PRECISE FEDERAL CONSULTING LLC, a small, women-owned business with multiple set-aside certifications, indicating policy-driven growth in HHS training programs. Key risks include the Whiting-Turner contract nearing its September 2024 end date, which may create re-compete uncertainty, and the nonprofit status of three recipients (Harvard, MRIGLOBAL, PRECISE FEDERAL) limiting direct equity investment opportunities. Overall, the digest reveals a civilian-focused, low-tech, stable procurement environment with limited public company exposure beyond Booz Allen Hamilton's $58.3 million CDC IT services contract.

5 total filings
· daily

All DOE Contracts — July 16, 2026

A single non-defense contract from the Department of Energy (DOE) to Accenture Federal Services LLC was recorded during the period, valued at $46.87 million in obligations out of a $56.96 million ceiling. This is a civilian-sector IT services award with consistent revenue recognition ($43.54 million outlayed), but it carries medium pricing and regulatory risk due to the firm-fixed-price structure and Accenture's foreign-owned status. The neutral signal and lack of defense exposure limit materiality for defense-focused portfolios. Investors should watch for follow-on awards post-July 2026 and any regulatory changes affecting foreign-owned contractors in DOE work.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — July 16, 2026

This digest covers a single $302.1 million civilian contract awarded to Whiting-Turner Contracting Company by the National Institutes of Health (NIH) for the renovation of Building 10's E-Wing in Bethesda, MD. The contract is 100% civilian, with zero defense exposure, and represents a steady but non-strategic institutional construction project. The highest-conviction signal is neutral, reflecting a large, competitively awarded firm-fixed-price contract that is roughly 55% complete, with no indications of expansion or disruption. A key risk is the September 2024 contract end date, which may trigger a re-compete or modification that could alter revenue visibility for Whiting-Turner.

1 total filings
· daily

High-Value Federal Grants ($5M+) — July 16, 2026

This digest of 20 high-value federal grants ($5M+) totaling $1.39 billion reveals a civilian-agency-dominated procurement landscape, with only one defense-related award (Northrop Grumman's $80.6M NASA Mars propulsion contract). The dominant theme is institutional construction and IT modernization across HHS (NIH), DHS (TSA), VA, and GSA, with notable sole-source wins for L3Harris ($913.4M potential FAA SBS II) and Smiths Detection ($74.6M TSA explosive detection) signaling durable incumbent positions. The highest-conviction signal is L3Harris's sole-source FAA award, providing a predictable $182.7M annual revenue stream through 2031. Key risk: the heavy concentration of firm-fixed-price contracts (12 of 20) transfers cost overrun risk to contractors, particularly for small businesses like The Trevino Group ($48.9M VA infrastructure) and AMCOR JV ONE ($58M VA EHRM upgrades) with limited balance sheets to absorb shocks.

20 total filings